Metoclopramide effect in improving feeding tolerance in neonates

The effect of metoclopramide therapy compared with placebo in improving oral feeding intolerance in preterm infants

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201305188680N3

Enrollment

120

Registered

2014-01-12

Start date

2014-01-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

enteral feeding intolerance. Perinatal digestive system disorder, unspecified

Interventions

Intervention 1: Metoclopramide. /13 mg/kg Q 8h intavenously. Intervention 2: sterile water for injection ./13 CC q 88 intravenously.

Treatment - Drugs

Metoclopramide. /13 mg/kg Q 8h intavenously

sterile water for injection ./13 CC q 88 intravenously

Eligibility

Sex/Gender

All

Age

3 Years to 28 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Preterm neonate less than 36 weeks with feeding intolerance ; neonate without anomaly; Exclusion criteria : neonate with congenital anomalies

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Enteral feeding intolerance. Timepoint: Q3h. Method of measurement: no vomitting,no gastric residua.	—

Secondary

Measure	Time frame
Complet full enteral feeding. Timepoint: daily. Method of measurement: volum of feeding per day.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMirhadi Mussavi

Ilam University Of Medical Sciences

Drmussavihadi@yahoo.com+98 41 1327 2094

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026